ReviewEuropean endocrinology2017

The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration.

James E Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.